🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we announced our 2024 year end financial results. We also provided business updates for the investment community. Details: bit.ly/4jaGpt6 #BladderCancer #Urology #UroOncology

The CG Oncology team is gearing up for an exciting #AUA25! We will share durability results from Phase 3 BOND-003 on cretostimogene grenadenorepvec as part of a Practice-changing, Paradigm-shifting Clinical Trials in Urology (P2s) session at Amer. Urol. Assn.’s 2025 Annual Meeting

BCG therapy is often used to treat early-stage #bladdercancer. However, a worldwide BCG shortage persists, and up to 65% of patients either do not respond or eventually develop disease recurrence after first-line BCG therapy. Hear from Trinity J. Bivalacqua of Penn Medicine as he

We're on the same page as Petros Grivas, Clinical Director of Genitourinary Cancers Program at Fred Hutch Cancer Center and Associate Professor of Oncology at the University of Washington, that collaboration is an essential part of #drugdevelopment. At CG Oncology, we see a world where urologic cancer patients

#AUA2025 is just around the corner! In a few days, we will be in fabulous Las Vegas for the Amer. Urol. Assn. (AUA) 2025 Annual Meeting. Join us for series of key presentations and updates to clinical trials evaluating our lead candidate, cretostimogene grenadenorepvec, across the

Join us on Monday, April 28 for a conference call and webcast to discuss the latest BOND-003 Cohort C and Cohort P data presented at #AUA2025. Details: bit.ly/3YaQMoD #Urology #UroOncology #BladderCancer #CancerResearch

New BOND-003 data presented at #AUA25 reinforce cretostimogene’s potential in BCG-unresponsive #NMIBC. Learn how data from Cohorts P and C build upon the body of clinical evidence on cretostimogene, demonstrating compelling response rates and sustained durability.

At CG Oncology, we are passionate about innovating on behalf of bladder cancer patients. In honor of #BladderCancerAwarenessMonth, we will be sharing a series of #DidYouKnow? facts every Friday to help raise awareness, close the gap, and make sure everyone knows the facts.

CG Oncology congratulates Drs. Saum Ghodoussipour, Rutgers Cancer Institute of New Jersey, and Taylor Goodstein, M.D., Emory University - recipients for the first annual Non-Muscle Invasive Bladder Cancer (NMIBC) CG-SUO-CTC NMIBC Research Fellowship. bit.ly/4d7z9fK

#BladderCancerAwarenessMonth #DidYouKnow? #FactFriday

Check out this article in FierceHealthcare to learn more about how, if approved, our lead investigational candidate, cretostimogene grenadenorepvec, could redefine the standard of care for non-muscle invasive bladder cancer (#NMIBC): bit.ly/3SxhbJT

Today we announced our financial results for the first quarter. We also provided business updates for the investment community. Details: bit.ly/42Xm59a #BladderCancer #Urology #UroOncology

#BladderCancerAwarenessMonth #DidYouKnow? #FactFriday

#BladderCancerAwarenessMonth #DidYouKnow? #FactFriday

At CG Oncology, we honor the men and women who made the ultimate sacrifice for our freedom today and always.

#BladderCancerAwarenessMonth #DidYouKnow? #FactFriday

Today is National Cancer Survivors Day which honors anyone living with a history of cancer - from the moment of diagnosis through the remainder of life. Together, let us bring attention to the ongoing challenges that cancer survivors face and celebrate life. #NCSD2025

Happy #PrideMonth! At CG Oncology we believe our differences make us stronger. We are proud to foster an inclusive and welcoming community for all.

The 2025 ASCO Annual Meeting is focused on driving cancer research into actionable change - that really resonates with our team here at CG Oncology. #ASCO2025 #CGOncology #BladderCancerCommunity #BCAN

Earlier this week our Chairman & Chief Executive Officer, Arthur Kuan, participated in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami Beach, FL. Thanks to #GoldmanSachs for the opportunity to talk about our progress towards developing and